Dynamic susceptibility-contrast perfusion-weighted MRI was performed on 15 chronic stroke patients receiving intracerebral implantation of peripheral blood stem cells (PBSC) at baseline and 6 longitudinal stages after therapy to derive relative cerebral blood volume around the implanted graft relative to contralateral white matter (rCBV ratio), with 15 control patients receiving baseline MRI plus two follow-ups. Nine of the 15 patients (60%) in the PBSC group showed significantly increased rCBV ratio than the baselines (1.39±0.60 versus 1.07±0.44; p < 0.01) at one week after implantation only, preceding functional improvements starting at one month as assessed by NIH stroke scale.
This abstract and the presentation materials are available to members only; a login is required.